Nanopower Medicine, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-20.
Nanopower Medicine, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 20, 2025. The filing reports $2K sold. Its industry group is Other Technology (SEC Form D, October 20, 2025).
Is this your company?
Sell to companies like Nanopower Medicine, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Nanopower Medicine, Inc.
Free to see. No signup.
More on the people and the money behind Nanopower Medicine, Inc., from the filings we hold.
Other Technology raises by companies based in California, filed in October 2025, largest first.
Get an email when Nanopower Medicine, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Nanopower Medicine, Inc. raises, hires or launches. No email unless you switch it on.
Watch Nanopower Medicine, Inc. →Get the full cited report on Nanopower Medicine, Inc.
What the filing shows about Nanopower Medicine, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nanopower Medicine, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Nanopower Medicine, Inc.'s address as 1608 W. Campbell Ave. #369, Campbell, CA 95008.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Nanopower Medicine, Inc. See pricing
Nanopower Medicine, Inc. is a registered filer with the SEC (CIK 2091944) and has filed since 2025-10-20. 1 filing is on record, the latest on 2025-10-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Nanopower Medicine, Inc.'s Form D of 2025-10-20 names Jay Zaveri, Jeffrey Cleland and Arjun Sethi as its officers, directors or promoters.
Its new offerings report $2K sold across 1 offering, as its own filings state.
Trailing twelve months. 3844 filings in Other Technology, totalled by week.
Proceeds are for working capital. The number above excludes the use of proceeds for ordinary course salary payments to executive officers.
On the filing as: Executive Officer, Director, Promoter.
Jay Zaveri is named as "Promoter" relationship is marked as this individual is a founder of the Issuer. on the Form D that Nanopower Medicine, Inc. filed with the SEC on 20 October 2025, one of 3 people that filing names.
On the filing as: Executive Officer, Director, Promoter.
Jeffrey Cleland is named as "Promoter" relationship is marked as this individual is a founder of the Issuer on the Form D that Nanopower Medicine, Inc. filed with the SEC on 20 October 2025, one of 3 people that filing names.
On the filing as: Executive Officer, Director, Promoter.
Arjun Sethi is named as "Promoter" relationship is marked as this individual is a founder of the Issuer. on the Form D that Nanopower Medicine, Inc. filed with the SEC on 20 October 2025, one of 3 people that filing names.
3 people named on the filing — 3 holding an executive role.
Named as of the 2025-10-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Nanopower Medicine, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nanopower Medicine, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nanopower Medicine, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Nanopower Medicine, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Nanopower Medicine, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Nanopower Medicine, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/nanopower-medicine-inc-form-d-25000001